Since the United States imposed an embargo on Cuba in 1961, the island nation has built a robust healthcare system on their own, with…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
Despite decades of study, the underlying cause of Alzheimer’s continues to evade scientists. Because it’s such a mystery, there are only six drugs approved for…
As Julie Fleming’s father slipped into the later stages of Alzheimer’s dementia, she could only watch as his computer skills and interests faded. “The…
A class of medications called cholinesterase inhibitors help to turn back the clock on Alzheimer’s disease’s cognitive symptoms. More than a third people over…
Alzheon’s new Alzheimer’s ALZ-801 drug is finishing up recruiting for Phase 3 clinical trials. If the trial proves successful, it may become the first…
Here’s a theory: Alzheimer’s biomarker beta-amyloid could — rather than killing the brain — actually be trying to defend it. The provocative idea builds on…